IDEXX Laboratories (BSP:I1DX34) Scaled Net Operating Assets : 0.70 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

IDEXX Laboratories's operating assets for the quarter that ended in Mar. 2024 was R$14,721 Mil. IDEXX Laboratories's operating liabilities for the quarter that ended in Mar. 2024 was R$3,564 Mil. IDEXX Laboratories's Total Assets for the quarter that ended in Dec. 2023 was R$15,973 Mil. Therefore, IDEXX Laboratories's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.70.

IDEXX Laboratories Scaled Net Operating Assets Historical Data

The historical data trend for IDEXX Laboratories's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Scaled Net Operating Assets Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.80

0.86

0.76

0.75

0.71

IDEXX Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.74	0.70	0.75	0.67	0.70

Competitive Comparison of IDEXX Laboratories's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, IDEXX Laboratories's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDEXX Laboratories's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Scaled Net Operating Assets falls into.

IDEXX Laboratories Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

IDEXX Laboratories's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(13748.805	-	3469.264)	/	14407.881
=	0.71

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	15972.981	-	2224.176
=	13748.805

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8699.08	-	3540.37	-	1689.446
=	3469.264

IDEXX Laboratories's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(14720.697	-	3563.879)	/	15972.981
=	0.70

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	16699.834	-	1979.137
=	14720.697

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8886.996	-	3608.647	-	1714.47
=	3563.879

IDEXX Laboratories Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (BSP:I1DX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines